A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

Merck & Co., Inc. (NYSE:MRK ... A variety of vaccinations and veterinary pharmaceutical products are developed, discovered, produced, and marketed by its Animal Health sector. The company's sales ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

Out of all of the special options we uncovered, 3 are puts, for a total amount of $141,686, and 10 are calls, for a total ...

Merck & Co. (MSD outside the U.S. and Canada) has just unveiled a brand-new, cutting-edge vaccine manufacturing facility at ...

Merck & Co. has penned a $300 million biobucks-per-product deal with cancer biotech ... tumor type,” according to the release. The U.S. pharma will have the exclusive rights to develop and ...

Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...

According to GlobalData’s Pharma Intelligence Center ... with the potential for additional milestone payments totalling up to ...

The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...